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C-to-U RNA editing of glycine receptors (GlyR) can play an important role in disease
progression of temporal lobe epilepsy (TLE) as it may contribute in a neuron type-specific
way to neuropsychiatric symptoms of the disease. It is therefore necessary to
develop tools that allow identification of neuron types that express RNA-edited GlyR
protein. In this study, we identify NH4 as agonist of C-to-U RNA edited GlyRs.
Furthermore, we generated a new molecular C-to-U RNA editing sensor tool that
detects Apobec-1- dependent RNA editing in HEPG2 cells and rat primary hippocampal
neurons. Using this sensor combined with NH4 application, we were able to identify
C-to-U RNA editing-competent neurons and expression of C-to-U RNA-edited GlyR
protein in neurons. Bioinformatic analysis of 1,000 Genome Project Phase 3 allele
frequencies coding for human Apobec-1 80M and 80I variants showed differences
between populations, and the results revealed a preference of the 80I variant to generate
RNA-edited GlyR protein. Finally, we established a new PCR-based restriction fragment
length polymorphism (RFLP) approach to profile mRNA expression with regard to
the genetic APOBEC1 dimorphism of patients with intractable temporal lobe epilepsy
(iTLE) and found that the patients fall into two groups. Patients with expression of
the Apobec-1 80I variant mostly suffered from simple or complex partial seizures,
whereas patients with 80M expression exhibited secondarily generalized seizure activity.
Thus, our method allows the characterization of Apobec-1 80M and 80l variants in
the brain and provides a new way to epidemiologically and semiologically classify iTLE
according to the two different APOBEC1 alleles. Together, these results demonstrate
Apobec-1-dependent expression of RNA-edited GlyR protein in neurons and identify the
APOBEC1 80I/M-coding alleles as new genetic risk factors for iTLE patients.
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INTRODUCTION
RNA editing plays an important role in the diversification of gene
products. There are two different types of enzymatic deamination
which lead either to the conversion of adenosine to inosine (A-to-
I RNA editing) or of cytidine to uridine (C-to-U RNA editing).
While the role of A-to-I RNA editing in health and disease is
being investigated by many laboratories, research on C-to-U
RNA editing is still at a rudimentary level (Meier et al., 2016).
In this study, we focused on C-to-U RNA editing and the
involvement of the apolipoprotein B (ApoB) mRNA editing
enzyme catalytic polypeptide-like Apobec-1. Successful cloning
of APOBEC-1, the first identified member of the APOBEC gene
family of cytidine deaminases (Navaratnam et al., 1993; Teng
et al., 1993), was a milestone in research on C-to-U RNA editing.
The role of APOBEC1 and auxiliary proteins in pre-mRNA
editing of ApoB in liver and small intestine was elucidated in
great detail (Backus and Smith, 1992; Schock et al., 1996; Dance
et al., 2002; Smith, 2007). However, C-to-U RNA editing may also
play a critical role in the central nervous system. In fact, C-to-U
RNA editing of gene transcripts coding for the neurotransmitter
receptor for glycine (GlyR) was discovered over 10 years ago
(Meier et al., 2005). In the case of GlyR, C-to-U RNA editing leads
to amino acid substitution of leucine for proline and receptor
gain-of-function (Meier et al., 2005; Legendre et al., 2009).
Using bulk material of resected hippocampi, GlyR C-
to-U RNA editing was shown to be increased in patients
with severe intractable temporal lobe epilepsy (iTLE) (Eichler
et al., 2008). Increased C-to-U RNA editing leads to neuronal
gain-of-function through presynaptic activity of RNA-edited
GlyRs, resulting in facilitation of neurotransmitter release
(Bischofberger et al., 2006; Meier et al., 2014). This ultimately and
persistently tilts the balance between excitation and inhibition
in a bidirectional way (Eichler and Meier, 2008). Depending
on the neuron type that is afflicted with increased GlyR C-
to-U RNA editing, cognitive dysfunction or persistence of
contextual fear memory can thus arise through enhanced
function of glutamatergic or parvalbumin type GABAergic
neurons, respectively, which has been shown in a corresponding
animal model of the disease (Winkelmann et al., 2014; Çaliskan
et al., 2016). Thus, methods for neuron type-specific detection of
RNA-edited GlyR protein are ultimately required to elucidate the
role of this gain-of-function neurotransmitter receptor in iTLE.
We present here novel molecular and chemical tools for
detection of C-to-U RNA editing at the single cell level.
Furthermore, the results identify an agonist that allows
discrimination between RNA-edited and non-RNA-edited GlyR
proteins in hippocampal neurons. The combination of these
novel molecular and chemical tools enable a proof-of-principle
demonstration of the role of Apobec-1 in C-to-U RNA editing of
GlyR and expression of the RNA-edited GlyR protein. Moreover,
bioinformatic analysis revealed worldwide differences in the
allelic distributions of two different APOBEC1 80I- or 80M-
coding alleles. Using a new PCR-based restriction fragment
length polymorphism (RFLP) approach we furthermore provide
a retrospective assessment of the iTLE patients analyzed in 2008
(Eichler et al., 2008) with regard to expression of Apobec-1
80I and 80M variants. The results showed that iTLE patients
with 80I expression mostly experienced simple or complex
partial seizures, whereas patients with 80M expression exhibited
secondarily generalized seizure activity. This establishes the basis
for a new mapping of epidemiology and semiology of iTLE with
regard to APOBEC1 80M/I alleles and opens up new ways to
functionally characterize the Apobec-1 80M and 80I variants in
the brain and in iTLE patients. Together, these results advance
our understanding of C-to-U RNA editing at the single cell level
and establish expression of the Apobec-1 80I and 80M variants as
new genetic risk factors of iTLE.
METHODS
Molecular Constructs
SV40 nucleus localization sequence-containing clones and
expression constructs containing the large cytosolic loops
between transmembrane domains TM3 and TM4 of GlyR α1ins
and α3K were amplified with PCR and cloned in frame with the
mCherry coding sequence of an in-house made vector derived
from EGFP-N1 (Clontech), using EcoRI and AgeI restriction
enzymes (Figure 1A). Corresponding cDNA clones (Legendre
et al., 2009) served as PCR templates. For construction of the
C-to-U RNA editing sensor, the Apobec1-consensus motive was
inserted upstream of the GlyR α3K TM4 domain using fusion-
PCR and BclI-restriction digest; BclI cleaves within the Apobec1-
consensus sequence. The resulting editing sensor construct thus
consists of the large cytosolic loop between TM3 and TM4 of
GlyR α3K followed by the Apobec1-consensus sequence and the
TM4. It reports C-to-U RNA editing according to the nuclear
translocation of mCherry, which changes due to C-to-U RNA
editing-dependent premature STOP and lack of TM4. Further
constructs were generated in which mCherry was replaced with
EGFP.
Apobec-1 complementation factor (ACF) and Apobec1-80I
or -80M vectors were purchased from Origene (Rockville, MD
20850, USA). The respective open reading frames (ORFs) were
subcloned into our in-house-made Thosea Asigna virus 2A-
peptide coding vectors (Winkelmann et al., 2015) and finally
also cloned upstream of the editing sensor-coding domain using
standard cloning techniques and the 2A-peptide as molecular
interface.
The EGFP-2A-GlyR α2-192P and -192L constructs were
obtained by cloning an EGFP-2A fragment upstream of the GlyR
ORF.
All final constructs were verified by DNA sequencing.
RT-PCR Analysis of C-to-U RNA Editing
Enzymes in Primary Rat Hippocampal
Neurons
Total RNA was isolated from primary hippocampal neurons
from E18 rat embryos (DIV8) and reverse transcribed into cDNA
as described earlier (Raltschev et al., 2016). Oligos were used to
amplify regions of AID (5′-GTCCGCTGGGCTAAGGGTC-3′
and 5′-GCACAGTCGTAGCAGGGGC-3′), APOBEC-1 (5′-CCC
TGTAGCTGTTGATCCCACTC-3′ and 5′-CAGAGTTACATG
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and 5′-AGCTTTGGGGGTGTGAAAGG-3′) and GAPDH
(5′-CAGTATGACTCTACCCACGG-3′ and 5′-CTCAGTGT
AGCCCAGGATG-3′). PCR products were analyzed using
electrophoresis with 1.2% agarose gels. Ethidium bromide was
used to stain DNA bands.
PCR-RFLP Analysis of Human TLE
Samples
Resected hippocampal tissue of human iTLE patients (Eichler
et al., 2008) was analyzed with regard to APOBEC1 gene
dimorphism coding for 80M or 80I Apobec-1 protein variants.
For this purpose, we developed a new PCR-based RFLP approach.
Total RNA was isolated and reverse transcribed into cDNA as
described earlier (Raltschev et al., 2016). Pre-amplification of
Apobec-1 was performed using oligonucleotides 5′-CTTCAAC
CGGTGACCCCACTC-3′ and 5′-TGCGTACAACATCATCC
ACAGAGG-3′. Then, 3.5 µl of the pre-PCR were investigated
in another PCR using oligonucleotides 5′-GAGTTTGACGTC
TTCTATGACCC-3′ and 5′-GTTGACAAAATTCCTCCAGCA
G-3′ to amplify a region spanning the 80M/I-coding position.
This nested PCR amplification step yielded sufficient amount of
DNA that was purified with Monarch R© DNA Gel Extraction Kit
(catalog no. L1020L, New England Biolabs GmbH) and digested
using NlaIII restriction enzyme. NlaIII cuts at the 80M-coding
position (CATG), and restriction fragments were separated using
electrophoresis with 5% agarose gels to identify the genotype
of the iTLE patients. For control purpose, Apobec-1 80I- or
80M-coding vectors for transfection were processed in parallel.
Ethidium bromide was used to stain DNA bands.
Cell Culture and Transfection
HEK293T cells and HEPG2 cells (generous gift by Dr. Markus
Kaiser, Department of Chemical Biology, University of Duisburg-
Essen, Germany) were cultured in T75 culture flasks containing
10ml of DMEM (catalog no. 41965-062, Gibco) supplemented
with 4.5 g/liter glucose, 10% FCS (catalog no. 1050064, Life
Technologies), and 1% penicillin/streptomycin (catalog no.
15140122, Life Technologies) at 37◦C and 5% CO2 in a
humidified incubator. Cell passaging was performed every 3–4
days at an average confluence of 80–90%.
For high-throughput image cytometry (Figure 1), HEK293T
cells were transfected at 70% confluency using a standard
Ca2+/phosphate protocol with 2 µg per 35mm cell culture dish.
Transfected cells were plated 1 day after transfection in black
96-well flat bottom Falcon microplates (BD, Franklin Lakes, NJ,
USA) at a density of 10,000 cells per well.
For analysis of subcellular C-to-U RNA editing sensor
distribution (Figure 3), HEPG2 cells were seeded onto uncoated
glass coverslips (diameter 13mm) 1 day before transfection.
Initial cell density was 50,000/cm2. Transfection of 2.5 µg
DNA was performed at 60–70% confluence with ViafectTM
Transfection Reagent (catalog no. E4981, Promega) according to
the manufacturer’s instructions.
Regarding HEK293T cells used for electrophysiology,
200,000 cells were seeded 2–3 days before transfection
onto 35-mm culture dishes containing 1.5ml of
DMEM/FCS/penicillin/streptomycin to reach 90–100%
confluence for transfection with FuGENE R© HD transfection
reagent (catalog no. 04 709 705 001, Roche Applied Science)
according to the manufacturer’s instructions. For HEK293T cells,
1 µg of DNA was used per transfection. For electrophysiological
recordings, transfected HEK293T cells were seeded onto glass
coverslips (diameter 13mm) coated for 20–30min with 0.1%
polyornithine (poly-dl-ornithine hydrobromide, catalog no.
P8638-100MG, Sigma). Cells were allowed to adhere for at least
2 h before electrophysiological recordings were carried out.
Primary hippocampal neuron cultures from E18 Wistar rats
were prepared as previously described (Winkelmann et al., 2014)
according to the permit given by the Animal Care Committee
of the Technical University Braunschweig (Zentrale Einrichtung
für Tierhaltung der TU Braunschweig, §4 10.15.M TSB TU BS)
and maintained in B27- and 1% FCS-supplemented Neurobasal
medium (Brewer and Cotman, 1989). The initial cell density was
68,000/cm2. Transfection and protein expression were carried
out as described (Winkelmann et al., 2014) on DIV6-9 using
Effectene transfection reagent (Qiagen, Hilden, Germany). For
transfection, coverslips were transferred to wells containing
transfection medium (Neurobasal supplemented with 0.25mM
L-glutamine) and incubated with complexes formed with 5 µl
of Effectene transfection reagent (Qiagen, Hilden, Germany) and
300 ng of DNA. If co-transfection was performed, editing sensor
and APOBEC1-80I or -80Mwere mixed using 150 ng, each. After
transfection, coverslips were transferred to dishes containing
expression medium based on glycine-free MEM, supplemented
with B27, 1% FCS, vitamin B12 and 0.25mM L-glutamine,
20mM D-glucose, 25µM β-mercaptoethanol, 230µM Na-
pyruvate and 1% penicillin/streptomycin.
Immunocytochemistry and Quantitative
Image Analysis
High-throughput image cytometry of transfected HEK293T
cells (Figure 1) was performed using Thermo Scientific
Cellomics Arrayscan VTI HCS Reader and the BioApplication
Compartemental Analysis protocol of the corresponding
software (Thermo Fisher Scientific, Waltham, MA, USA). For
this purpose, cell nuclei were stained and identified using
1:2,500-diluted Hoechst 33342 (Invitrogen, Life Technologies,
Carlsbad, CA, USA).
For analysis of subcellular C-to-U RNA editing sensor
distribution (Figures 3, 4), transfected cells (HEPG2 or primary
hippocampal neurons) were fixed 1 day after transfection using
a mixture of ice-cold 4% paraformaldehyde and 4% sucrose.
HEPG2 cells were mounted using DAPI-containing Vectashield
(Vector Laboratories, Burlingame, CA, USA). Primary neurons
were permeabilized using 0.12% Triton X100 and further
processed for immunocytochemistry with guinea pig antibody
against MAP2 (catalog no. 188004, Synaptic Systems) and
donkey anti-guinea pig CY5 (catalog no. 706-175-148, Jackson
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FIGURE 1 | The GlyR transmembrane domain 4 (TM4) determines cytosolic localization of the GlyR TM3-4 loop in HEK293T cells. (A) Design of molecular constructs.
Upstream of mCherry, different sequences were cloned including SV40 NLS (KKKRK), GlyR α1 loop NLS (RRKRR), and GlyR α1ins TM3-4 without or with the TM4.
The respective constructs were also established for the GlyR α3 subunit. (B) Representative images showing fluorescence signals of mCherry constructs (red) and
DAPI (green). (C) Quantification of the fluorescence ratios (nucleus/cytosol) of mCherry signals using Cellomics plate reader software in live cells stained with Hoechst
33342. Note that the most pronounced difference between nucleus/cytosol ratios of GlyR TM3-4 constructs with or without the TM4 domain was observed for the
GlyR α3 subunit. Significance levels are given for conditions compared to control (*), compared to SV40-NLS (#), compared to α1ins loop (§) and compared to α3K
loop (‡). In all cases, three symbols mark statistical significance (P < 0.001), as assessed using Mann-Whitney test. At least 1,000 cells per condition and cell culture
plate well were analyzed. The number of wells analyzed in 3 independent experiments is indicated in brackets (see Table 1).
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ImmunoResearch) to identify neurons, before mounting in
Vectashield with DAPI.
Using Metamorph software (Molecular Devices, Sunnyvale
CA), line scans were applied so that the lines covered cytosol
and nucleus of transfected cells (Figures 3, 4). Fluorescence
intensity values along the scanned lines were acquired using
Excel software (Microsoft, Redmond WA, USA). Subsequently,
the pixel intensity values were divided into cytosolic and nuclear
parts of the cell according to the DAPI signal. Finally, the ratio
between mean nuclear and cytosolic pixel intensities per cell was
calculated.
Electrophysiology
Transfected neurons were recorded between DIV7 and 15. A
ListMedical amplifier, an ITC-18 interface, and Patchmaster
software (HEKA, Lamprecht, Germany) were used for patch
clamp recordings and data acquisition. Patch pipettes, made from
borosilicate glass (Science Products, Hofheim, Germany), had
resistances of 3–7 M when filled with the intracellular solution
containing (in mM): CsCl (130), NaCl (5), CaCl2 (0.5), MgCl2
(1), EGTA (5), and HEPES (30), pH 7.2 (CsOH). The standard
extracellular solution contained (in mM): NaCl (140), KCl (5),
MgCl2 (1), CaCl2 (2), HEPES-NaOH (10) and glucose (10), pH
7.4 (NaOH). Cells were clamped at a potential of−50mV. Series
resistances (Rs), monitored by −5mV voltage pulses (50ms)
applied every 5 s, were between 10 and 40 M. In the figures,
the responses to the voltage pulses are not shown, resulting in a
discontinuous appearance of current traces. However, for better
legibility of the figures we filled these gaps in displayed recording
traces. Experiments withmore than 25% change in Rs throughout
the recording were discarded. Data were acquired at a sampling
rate of 10 kHz after filtering at 2.8 kHz. Transfected cells were
identified according to EGFP or mCherry fluorescence. If not
stated otherwise, voltage clamp data were recorded in standard
extracellular solution in the presence of tetrodotoxin (TTX,
0.3µM; Sigma), D-aminophosphonovaleric acid (APV, 50µM;
Cayman Chemical), 6,7-dinitroquinoxaline-2,3-dione (DNQX,
10µM, Cayman Chemical), and bicuculline methiodide (20µM;
Sigma). This drug mixture called ABDT was used in most
experiments and supplemented with ammonium chloride (0.5–
50mM), strychnine (1 or 10µM) and glycine (100µM), where
indicated.
Perfusion of the extracellular solutions was gravity-driven.
A perfusion pencil with a 250-µm tip placed at a distance of
100–200µm from the recorded cell was used to obtain relatively
short wash-in/wash-out times (<1 s). Analysis of patch clamp
data was performed with in-house software written in IGOR
6.37 (WaveMetrics, Lake Oswego, USA) by M. Semtner. Live
imaging of transfected neurons was done before establishing
contact with the patch pipette using a Zeiss Axioscope 10
(Carl Zeiss, Jena, Germany) equipped with a 40x objective, a
custom made mCherry and EGFP filter set (Chroma Technology
GmbH), an Uniblitz electronic shutter and a Spot Pursuit 2M
pixel monochromeCCD camera. Exposure times ranged between
1 and 3 s, and images were acquired with Metamorph 7.1
(Molecular Devices).
Statistics
Normal distribution of data was assessed using Shapiro-Wilk test.
If normal distribution was given, data was subjected to one-way
ANOVA with post-hoc Tukey-test. If normal distribution was not
given, data was subjected to Mann-Whitney test. If not stated
otherwise, all data are given as mean ± SEM.). Asterisks used to
indicate statistical significance were defined as follows: “n.s.” (not
significant) = P > 0.05; one symbol = P < 0.05; two symbols =
P < 0.01; three symbols= P < 0.001.
RESULTS
Recent studies identified the intracellular large cytosolic loop
between transmembrane domains 3 and 4 (TM3-4 loop) as a
highly efficient nuclear targeting domain (Melzer et al., 2010;
Förstera et al., 2014). Here, we revisited and corroborated
these findings and furthermore show that addition of the
transmembrane domain 4 (TM4) efficiently prevents nuclear
import of GlyR α1 and α3 TM3-4 loops and hence is a dominantly
acting cytosol-retaining domain. Figure 1A shows the molecular
design of the constructs used here. We used TM3-4 loops of
GlyR α1ins and α3K splice variants as described (Förstera et al.,
2014). These domains were cloned downstream of mCherry. For
control purpose, mCherry alone or equipped with SV40 NLS
(KKKRK) were used. Furthermore, we included the TM4 in
the TM3-4 loop constructs of GlyR α1ins and α3K. Figure 1B
shows representative images of transfected HEK293T cells. Note
that the GlyR α1ins and α3K TM3-4 loops (red) efficiently
targeted the nucleus (green), while the TM4 domain efficiently
overrode the nuclear targeting activity of the TM3-4 loops and
led to almost exclusive cytosolic localization of the mCherry
signal (Figure 1C). Quantification of the ratio between nuclear
and cytosolic fluorescence intensities and statistical analysis
demonstrated the dominant effect of the TM4 over TM3-4 loops
(Figure 1, Table 1).
TABLE 1 | Assessment of nuclear targeting capacity of large cytosolic GlyR loop domains.
Control SV40-NLS α1-NLS α1ins loop α1ins loop TM4 α3-NLS α3K loop α3K loop TM4
N 30 24 18 18 12 24 24 18
Mean 2.11 6.85 3.59 6.74 0.86 5.99 12.05 1.22
SD 0.29 1.16 0.59 1.07 0.10 1.02 1.54 0.08
SEM 0.05 0.24 0.14 0.25 0.03 0.21 0.31 0.02
The table shows values corresponding to ratios of nuclear to cytosolic fluorescence intensities in transfected HEK293T cells. N, number of wells; SD, standard deviation; SEM, standard
error of the mean.
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These clear-cut results prompted us to develop a C-to-
U RNA editing sensor (Figure 2). As the GlyR α3K TM3-4
with and without TM4 provided most accentuated results
regarding nuclear vs. cytosolic targeting, the human Apobec-
1 consensus sequence derived from apolipoprotein B was
inserted between the C-terminal end of the TM3-4 loop
of GlyR α3K and the N-terminus of the GlyR α3 TM4
domain (Figure 2A). However, in contrast to the constructs
used in Figure 1, the fluorescent reporter protein was inserted
upstream of the C-to-U RNA editing sensor GlyR TM3-4
domain to indicate Apobec-1-dependent RNA editing through
translocation of the fluorescence into the nucleus. Editing
of the CAA codon to the STOP codon UAA should thus
result in nuclear targeting of the reporter fluorescence protein
(here EGFP upstream of the sensor domain). In order to
test the efficacy of the editing sensor, we used the recently
established faithful multicistronic co-expression technology
(Tang et al., 2009). Editing sensor was either expressed alone or
in combination with human Apobec-1 complementation factor
(ACF) and Apobec-1 80I or 80M variants, using the Thosea
asigna virus 2A self-processing peptides (Tang et al., 2009;
Figure 2B).
We investigated the functionality of these constructs using the
C-to-U RNA editing-deficient liver carcinoma cell line HEPG2
(Chen et al., 2010). As Apobec-1 was previously associated with
C-to-U RNA editing of apolipoprotein B and GlyR (Backus
and Smith, 1992; Meier et al., 2005), we assessed the effect
of Apobec-1 80M and 80I on the subcellular localization of
the editing sensor. Figures 3A–C show representative images
of HepG2 cells expressing EGFP-editing sensor (A, control)
or ACF-Apobec-1 80M/I-editing sensor constructs shown in
Figures 2B, 3B,C. Quantification using line scans of fluorescence
intensities in cytosol and nucleus of the transfected cells
(Figure 3D) corroborated the marked first impression of
prominent nuclear targeting of the sensor upon 2A-peptide-
dependent co-expression of 80M or 80I Apobec-1 variants [mean
fluorescence ratios between nucleus and cytosol; editing sensor
alone: 0.761± 0.114 (mean± SD), editing sensor with Apobec-1
80M or 80I: 2.031± 0.646 (mean± SD) and 2.324± 0.659 (mean
± SD), respectively; Figure 3E].
To pursue these promising results, we next characterized the
performance of the editing sensor in rat primary hippocampal
neurons (Figure 4). Figures 4A–C shows representative images
of primary neurons expressing EGFP-editing sensor (Figure 4A,
control) or ACF-Apobec-1 80M/I-editing sensor constructs
shown in Figures 2B, 4B,C. As in HEPG2 cells, quantification
using line scans of fluorescence intensities in cytosol and
nucleus of the transfected neurons (Figure 4D) revealed
that nuclear targeting of the editing sensor was increased
upon 2A-peptide-dependent co-expression of 80M or 80I
Apobec-1 variants [mean fluorescence ratios between nucleus
and cytosol; editing sensor alone: 0.763 ± 0.187 (mean
± SD), editing sensor with Apobec-1 80M or 80I: 1.940
± 0.316 and 2.197 ± 0.407 (mean ± SD), respectively;
Figure 4E].
Our pharmacological screens (Schneidereit et al., 2017)
suggested NH4 as agonist of RNA-edited GlyRs, which may
allow discrimination of non-edited and edited GlyRs. To address
this possibility in detail, we used transfected HEK293T cells
and performed whole cell patch clamp analysis (Figure 5).
FIGURE 2 | Molecular design of the C-to-U RNA editing sensor. (A) The human Apobec-1 consensus sequence was inserted downstream of EGFP-coding sequence
between the C-terminal end of the TM3-4 loop of GlyR α3K and the GlyR α3 TM4 domain. Editing of the CAA codon to the STOP codon UAA should result in nuclear
targeting of the reporter fluorescence protein (here EGFP). (B) Using the Thosea asigna virus 2A self-processing peptides, additional constructs with human ACF and
Apobec-1 (80I or 80M variants) were generated in order to test the efficacy of the editing sensor in response to equimolar multicistronic expression of the
corresponding enzyme complex subunits.
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FIGURE 3 | The C-to-U RNA editing deficient HEPG2 liver carcinoma cell line was used to evaluate the functionality of the RNA editing sensor. (A–C) Representative
images of HEPG2 cells transfected with the constructs shown in Figure 2B. Images show fluorescence corresponding to DAPI (left panels), sensor signals (middle
panels), and merged signals (right panels) without (A, control, editing sensor alone) or with Apobec-1 80M (B, 80M) or Apobec-1 80I (C, 80I) co-expression. Dotted
lines show examples of the placement of line-scans shown in (D). (D) Line scans of pixel intensities of the editing sensor (green) and DAPI (red) through cytosol and
nucleus in the three different conditions are shown. Dotted red vertical lines delineate the nuclear region in each case (“Nucleus”). (E) Quantification of the fluorescence
ratios between nucleus and cytosol in line-scanned specimen. All data are given as mean ± SD. Asterisks mark significant differences between editing sensor alone
and with 80M or 80I. The “##” symbol indicates a significant difference (P = 0.006) between 80M and 80I while *** mark significant differences between control and
80M or 80I (P < 0.001), as assessed using Mann-Whitney test. The number of analyzed cells is indicated in brackets.
We focused here on the GlyR α2 subunit because primary
hippocampal neurons at DIV8-13 predominantly express GlyR
α2 (Meier and Grantyn, 2004; Raltschev et al., 2016). However,
as both splice variants of GlyR α2 (Figures 5A,B) and the GlyR
α3L subunit are expressed in the iTLE hippocampus (Eichler
et al., 2008), we included bothGlyR α2 splice variants (Figure 5B)
and GlyR α3L (Supplementary Figure 1) into our analyses. Thus,
we co-expressed EGFP and GlyR α2A-192P/L, α2B-192P/L,
or α3L-185P/L in HEK293T cells and recorded the currents
in response to 5–50mM NH4 and 100µM glycine (Figure 5,
Supplementary Figure 1). Quantification of the current ratios
revealed that 10mM NH4 is the most suitable concentration for
effective discrimination between non-edited and edited α2- and
α3-GlyRs (Figure 5B, Supplementary Figure 1). Furthermore,
strychnine blocked NH4-elicited currents, indicating that NH4
indeed activated GlyRs (for values see Table 2, Supplementary
Table 1).
To investigate endogenous expression of RNA-edited
GlyR protein, we transfected primary hippocampal neurons
with the editing sensor, in which EGFP was substituted by
mCherry (above, Figures 2–4), alone or in combination
with ACF-Apobec-1 80M/I-EGFP variants (Figure 6A). As
control, EGFP was co-transfected with the editing sensor.
The co-transfection experimental approach was used here to
detect subcellular localization of the Apobec-1 variants and
the editing sensor simultaneously in live neurons. Figure 6A
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FIGURE 4 | Primary rat hippocampal (RHC) neurons were used to evaluate the functionality of the RNA editing sensor. (A–C) Representative images of RHC neurons
transfected with the constructs shown in Figure 2B. Images show fluorescence corresponding to DAPI (left panels), sensor signals (middle panels), and merged
signals including MAP2-stain shown in blue (right panels) without (A, control, editing sensor alone) or with Apobec-1 80M (B, 80M) or Apobec-1 80I (C, 80I)
co-expression. Dotted lines show examples of the placement of line-scans quantified in (E). (D) Examples of line scans of pixel intensities of the editing sensor (green)
and DAPI (red) through cytosol and nucleus in the three different conditions. The dotted red vertical lines delineate the nuclear region (“Nucleus”). (E) Quantification of
the fluorescence ratios between nucleus and cytosol in line-scanned specimen. All data are given as mean ± SD. Asterisks mark significant differences between
editing sensor alone and with 80M or 80I. The “#” symbol indicates a significant difference (P = 0.034) between 80M and 80I while *** mark significant differences
between control and 80M or 80I (P < 0.001), as assessed using one-way Anova followed by post-hoc Tukey test. The number of analyzed cells is indicated in
brackets.
shows representative images of live neurons expressing mCherry
editing sensor (middle panels) with either EGFP (control,
upper row), Apobec-1 80M-EGFP (middle row), or Apobec-1
80I-EGFP (lower row). Analysis of the fraction of neurons
with nuclear sensor localization revealed that 25.5% of EGFP-
expressing neurons had a nuclear sensor localization (12 out
of 47; Figure 6B, upper row). Upon coexpression of Apobec-1
80M, 77.5% (62 out of 80) showed a nuclear sensor localization
(Figure 6B, middle row), whereas 98.6% (71 out of 72) of
neurons showed nuclear sensor localization upon Apobec-
1 80I expression (Figure 6B, lower row). We finally tested
neurons with nuclear sensor localization for NH4 responsiveness
(Figures 6C–E). In the EGFP control group, the mean ratio
between current amplitudes elicited by 10mM NH4 and 100µM
glycine was 0.033 ± 0.009 (n = 16; Figure 6D). Both, Apobec-1
80M and 80I variants increased this ratio to 0.064 ± 0.021 (n =
16) and 0.089 ± 0.032 (n = 10), respectively (Figure 6D). The
fraction of NH4-responsiveness was then calculated according
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FIGURE 5 | Whole cell patch clamp analysis of transfected HEK293T cells
reveals the potential of NH4 to activate RNA-edited, not the non-edited, GlyR
α2 at physiological concentrations. (A) HEK293T cells were transfected with
non-edited GlyR α2 (192P, upper panel) or C-to-U RNA-edited GlyR α2 (192L,
lower panel). Traces of electrophysiological recordings show NH4
dose-dependent effects on GlyR currents. Note that 5 and 10mM NH4
resulted in significantly stronger activation of RNA-edited GlyR α2 compared to
non-edited GlyR α2. At a concentration of 50mM NH4 both types of receptors
were comparably activated. Currents could be blocked with 10µM strychnine
(Stry). For normalization, current responses to 100µM glycine were acquired in
the same cells. (B) Quantification of NH4-elicited currents relative to currents
elicited with 100µM glycine. Asterisks mark significant differences (*P <0.05,
***P < 0.001), as assessed using one-way Anova followed by post-hoc Tukey
test. For information about the number of analyzed cells see Table 2.
to amplitude ratios between NH4- and glycine-dependent
responses that were above 0.033, which corresponded to the
mean ratio we measured in the EGFP control group (Figure 6E).
Although slightly increased in both 80M and 80I conditions,
the ratios between current amplitudes elicited by 10mM NH4
and 100µM glycine in NH4-responsive neurons was not
significantly different (control: 0.076 ± 0.016, n = 5; 80M:
0.151 ± 0.033, n = 6; 80I: 0.140 ± 0.042, n = 6). However,
this revealed that Apobec-1 80I almost doubled the fraction of
NH4-responsive neurons (60%, 6 out of 10), compared to control
neurons (EGFP, 31.25%, 5 out of 16 neurons) or neurons with
Apobec-1 80M expression (37.5%, 6 out of 16; Figure 6E). Thus,
human Apobec-1 80I is more efficient than the 80M variant in
generating RNA-edited GlyR protein in primary rat hippocampal
neurons.
Two different genomic human APOBEC1 variants are
annotated (NCBI Reference Sequences NM_001644.4 and
AAA64230.1 coding for 80M and 80I, respectively). Through
a bioinformatic analysis of 1,000 Genome Project Phase 3
allele frequencies we investigated the world-wide distribution
of genotypes corresponding to APOBEC1 80M- and 80I-
coding alleles (Figure 7, Supplementary Table 2; note that the
human APOBEC1 reference gene sequence is annotated in
antisense direction of the ORF-coding sequence). This analysis
revealed that the 80I-coding allele is most frequent world-wide
(Figure 7A, “ALL,” G: 66%). The European population leads with
89% of individuals harboring the 80I-coding allele (Figure 7A,
“EUR”), followed by the South Asian population (Figure 7A,
“SAS,” G: 77%), the American population (Figure 7A, “AMR,”
G: 62%), East Asian and African population (Figure 7A, “EAS,”
“AFR,” G: 56%, and 50%, respectively). Figures 7B,C reveal
the distribution of homo- and heterozygous allele carriers. The
broader European population (EUR) featured 496 out of 503
reads (98.6%) which detected at least one allele coding for 80I;
while the frequency drops to 75.0% in the African population
(AFR); see Supplementary Table 2 for details.
Given the world-wide heterogeneity of 80I- and 80M-coding
APOBEC1 allele frequencies and regarding the preference of
the Apobec-1 80I variant to generate RNA-edited GlyR protein,
we wondered whether iTLE patients analyzed in 2008 with
regard to GlyR RNA editing (Eichler et al., 2008) expressed the
80I- or 80M-coding allele. For this purpose, we developed an
assay for detecting Apobec-1-coding mRNAs. The 80M-coding
sequence gives rise to an NlaIII restriction site CATG and
thus allows discrimination of 80M- and 80I-coding APOBEC1
gene transcripts according to different restriction fragment
lengths (Figure 8A). As control and restriction fragment lengths
reference, cDNA clones encoding Apobec-1 80M or 80I were
processed in parallel, and GAPDH was amplified to ensure
integrity of cDNA probes. We analyzed the 23 iTLE samples
published in 2008 (see Table 1 in Eichler et al., 2008 for details
on iTLE patients). Representative examples of the results of the
PCR-RFLP experiments are shown in Figure 8B. Nineteen out
of 23 samples showed Apobec-1 mRNA expression. In detail, 14
out of 19 expressed 80I-coding mRNA, and 5 out of 19 expressed
80M-coding mRNA. Thus, a fraction of 74% expressed the 80I-
coding allele, which is lower than expected according to the data
provided by our bioinformatics analysis (above, Figures 7B,C).
With regard to anamnesis data of the iTLE patients analyzed
in 2008, we found that the majority of patients (13 of 14) with
Apobec-1 80I expression (93%) suffered from simple and/or
complex partial seizure activity. In contrast, 2 out of 5 iTLE
patients with expression of the 80M allele (40%) experienced
secondarily generalized tonic clonic seizures, with 4 out of the 5
iTLE patients with 80M expression belonging to the W2-4 group
(Eichler et al., 2008).
DISCUSSION
Changes in neural network homeostasis due to maladaptive
changes in presynaptic plasticity and resulting persistent
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TABLE 2 | Whole cell patch clamp recording of transfected HEK293T cells.
5mM (192P) 10mM (192P) 50 mM (192P) 50mM + 10µM Stry
(192P)
5mM (192L) 10mM (192L) 50mM (192L) 50mM + 10µM Stry
(192L)
N 11 12 9 8 12 13 7 11
Mean 0.013 0.052 0.577 0.117 0.250 0.550 0.696 0.019
SD 0.020 0.045 0.241 0.098 0.208 0.278 0.126 0.031
SEM 0.006 0.013 0.080 0.035 0.060 0.077 0.048 0.009
N 9 9 9 9 9 9 9 8
Mean 0.030 0.139 0.832 0.161 0.789 0.814 0.901 0.014
SD 0.055 0.194 0.355 0.273 0.179 0.279 0.282 0.043
SEM 0.018 0.065 0.118 0.091 0.059 0.092 0.094 0.015
Applied NH4 concentration is indicated in mM. The upper part of the table represents current response ratios to 100µM glycine and the indicated NH4 concentrations in cells expressing
the GlyR α2A splice variant, while the lower part shows characteristics of GlyR α2B-expressing cells. “192P” denotes conditions with non-edited GlyR expression, while “192L” indicates
cells expressing the RNA-edited GlyR. N, number of cells; SD, standard deviation; SEM, standard error of the mean; Stry, strychnine.
neuronal gain or loss of function can play a critical role
in neuropsychiatric comorbidities of iTLE. In more detail,
we showed that presynaptic expression of gain-of-function
C-to-U RNA-edited GlyR leads to neuronal gain of function and,
depending on the affected neuron type, elicits either cognitive
dysfunction or persistence of contextual fear memory (Meier
et al., 2014, 2016; Winkelmann et al., 2014; Çaliskan et al., 2016).
Recent advances in sequencing technologies provide insights into
global changes in RNA editing, but they are not able to draw
conclusions on the cell/neuron type-specific changes involved
in maladaptive plasticity in disease as they use bulk material.
Thus, innovative technologies are required to assess changes
in posttranscriptional RNA processing at the single cell level.
Here, we present novel molecular and chemical tools for the
investigation of changes in C-to-U RNA editing at the single cell
level. Furthermore, our results highlight a possible link between
Apobec-1 80I expression and simple or complex partial seizure
activity.
Our molecular sensor tool indicates C-to-U RNA editing by
nuclear translocation of a fluorescence protein, which provides
a major advance compared to a recently published alternative
tool that involves kinetics of EGFP protein turnover (Severi and
Conticello, 2015). Our tool does not involve protein stability
but fast kinetics of nuclear import at a time scale of seconds
(Förstera et al., 2014). Thus, our sensor tool will be applicable
to assess acute changes in Apobec-1 enzyme activity. Indeed,
our new tool reliably indicated C-to-U RNA editing: Equimolar
co-expression of the editing sensor and 2A-peptide-dependent
Apobec-1 80M and 80I variants demonstrated efficient nuclear
translocation of the sensor protein in the C-to-U RNA editing-
deficient cell line HEPG2 (Figure 3). Moreover, we showed
that our editing sensor works equally well in transfected rat
primary hippocampal neurons (Figure 4). Our live cell imaging
experiments furthermore revealed that spontaneous C-to-U
RNA editing by the rat Apobec-1 80T variant (in the absence
of co-expressed human Apobec-1) occurred in about 25% of
sensor-expressing primary hippocampal neurons. In fact, our
experiments revealed that expression of human Apobec-1 80I
and the auxiliary protein ACF rendered almost all 80I-expressing
neurons editing competent (Figure 6), and they showed that the
80I variant was significantly more effective in translocating the
sensor to the neuronal nucleus compared to the 80M variant
(Figure 4E).
The C-to-U RNA editing sensor tool presented here reliably
indicated RNA editing in HEPG2 cells and primary neurons,
but it did not allow to draw conclusions on GlyR C-to-U
RNA editing. For this purpose, a combined approach involving
NH4 action on RNA-edited GlyRs and the sensor tool was
required. Indeed, we showed that application of 10mM NH4
elicits strychnine-sensitive RNA-edited GlyR-dependent currents
in transfected HEK293T cells. However, the fractions of C-to-
U RNA editing-competent and NH4-responsive neurons in the
context of rat endogenous neuronal Apobec-1 80T expression
or human Apobec-1 80M overexpression were rather low (31.3
vs. 37.5%). Overexpression of the human Apobec-1 80I variant
increased this fraction to about 60% of neurons with nuclear
sensor localization. This result reveals a preference of Apobec-1
80I for GlyR α2 C-to-U RNA editing and indicates that neuronal
GlyR α2 C-to-U RNA editing is regulated, depending on the
amino acid at position 80 of the polypeptide chain of Apobec-1.
The ratio between current amplitudes generated by 10mM NH4
and 100µM glycine in transfected HEK293T cells with RNA-
edited GlyR α2-192L was about 10 times higher compared to
neurons that overexpressed Apobec-1 80M or 80I in primary
rat hippocampal neurons (Figure 5 vs. Figure 6). This supports
neuronal endogenous regulation of GlyR C-to-U RNA editing
and furthermore indicates that about 10% of endogenous rat
neuronal GlyR α2 were edited in NH4-responsive and C-to-U
editing-competent neurons. This fraction corresponds well with
the fraction of RNA-edited GlyR α2 in iTLE patients with a severe
course of disease (Eichler et al., 2008). However, all the other
C-to-U editing enzymes expressed in primary rat hippocampal
neurons may also contribute to neuronal regulation of GlyR
α2 RNA editing, even irrespectively of ACF (Supplementary
Figure 2). In agreement with a recent study (Snyder et al., 2017),
co-expression of ACF with Apobec-1 80M or 80I did not affect
the preference of Apobec-1 80I over 80M for GlyR α2 C-to-U
RNA editing.
The preference of Apobec-1 80I over 80M for expression of
GlyR α2 C-to-U RNA-edited protein in neurons led us to develop
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FIGURE 6 | Application of 10mM NH4 reveals endogenous expression of RNA-edited GlyR protein in primary hippocampal neurons. (A) We co-transfected here the
mCherry editing sensor either without Apobec-1 (EGFP, control) or with EGFP-tagged ACF-Apobec-1 80M or 80I to check the nuclear localization of the ectopically
expressed human Apobec-1 protein in RHC neurons. Representative images document preferential cytosolic localization of the editing sensor in neurons
co-transfected with EGFP (control, upper panel). In contrast, co-expression of Apobec-1 80I or 80M variants triggered nuclear localization of the editing sensor.
(B) Quantification of the fraction of neurons with editing sensor in nucleus vs. cytosol in the three different conditions. (C) The example trace shows NH4
responsiveness of a neuron expressing Apobec-1 80I. Spontaneous neuronal activity was acquired for control purpose (left-hand) and blocked using TTX, APV and
DNQX, and bicuculline (BIC) during acquisition of responses to 10mM NH4. (D) Quantification of the ratio of peak amplitudes of 10mM NH4- and 100µM
glycine-evoked currents in EGFP (control) or Apobec-1 80M or 80I overexpressing neurons with nuclear sensor localization, representing C-to-U RNA
editing-competent neurons. Statistical analysis using Mann-Whitney test did not reveal significant differences (“n.s.”, P > 0.05); the number of investigated neurons is
indicated in brackets. (E) Quantification of the fraction of neurons with nuclear editing sensor localization and NH4-responsiveness reveals an Apobec-1
80I-dependent increase of the expression of RNA-edited GlyR protein (31.3 vs. 60.0%). Note that a NH4-responsive neuron was determined if the amplitude ratio
between 10mM NH4- and 100µM glycine-evoked currents was above 0.033 (EGFP control condition).
a new approach for the retrospective study of mRNA expression
of Apobec-1 80M and 80I in iTLE samples (Eichler et al., 2008).
Based on the fact that the 80M-coding sequence generates an
NlaIII restriction site, we investigated mRNA preparations of
previously characterized iTLE patients (Eichler et al., 2008). We
chose investigation of mRNA derived from these iTLE patients
because this approach unambiguously provides information
about Apobec-1 mRNA expression even if a heterozygous genetic
APOBEC1 background exists. In contrast to the rather low overall
representation of theAPOBEC1 80M-coding allele in our analysis
of allele frequency distributions in Europe (11%, Figure 7A),
assessment of heterozygosity in this population revealed a higher
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FIGURE 7 | Bioinformatic analysis of 1000 Genome Project Phase 3 allele frequencies coding for human Apobec-1 80M and 80I variants reveal world-wide
differences. (A) Note that the C allele codes for 80M (shown in blue) while the G allele codes for 80I (shown in yellow). Details about frequencies are shown in
Supplementary Table 2. SNP: rs2302515. Ref allele: C, ancestral allele: G. This analysis indicates that the European population predominantly encodes the
80I-Apobec-1 variant, compared to, for example, only 50% of the African population. (B) Representation of homo- and heterozygosity of APOBEC1 80M- and 80I-
coding alleles. Bar graph shows the frequency of the alleles in populations, with the number showing the sequenced alleles in phase 3 of the 1,000 Genomes Project.
Homozygous 80M-coding (CC, blue), heterozygous 80M-/80I-coding (CG, gray), and Homozygous 80I-coding (GG, yellow). (C) Representation of homo- and
heterozygosity of APOBEC1 80M- and 80I- coding alleles in super-population. Bar graph shows the frequency of the alleles in populations, with the number showing
the sequenced alleles in phase 3 of the 1000 Genomes Project. Homozygous 80M-coding (CC, blue), heterozygous 80M-/80I-coding (CG, gray), and homozygous
80I-coding (GG, yellow).
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FIGURE 8 | Retrospective APOBEC1 mRNA expression profiling of iTLE patients. (A) Sequences of human Apobec-1 80M and 80I including NlaIII restriction site in
the 80M variant (underlined) are shown. Amino acid sequence is shown in single letter code. (B) NlaIII digest results in bands of the following sizes (in bps, and
indicated by asterisks). 80M: 73, 102, 107, 129; 80I: 73, 107, 231. The agarose gels show expected DNA bands resulting from restriction digest with NlaIII. For
control purpose, 80M- and 80I-coding cDNA clones (58.4.1 and 58.4.3, respectively) were amplified and processed in parallel. Upper and lower panels:
representative analysis of Apobec-1 80I and 80M expression, respectively. Note that assessment of patient ID 2.34.4 was repeated because restriction digest failed in
the first run. M = gene ruler DNA size marker. bp = base pairs.
fraction (20%) of persons with at least one allele that codes
for the 80M Apobec-1 variant (Figure 7C, see Supplementary
Table 2 for details). Departing from this allele-distribution in our
sample of the general European population, 26% of the iTLE
patients analyzed in 2008 expressed the 80M allele, and 4 out of
5 iTLE patients with 80M expression belong to the W2-4 group
of iTLE patients with increased expression of RNA-edited GlyR
(Eichler et al., 2008). Although we can’t retrospectively provide
information regarding the ethnic origin of these patients, this
result suggests an overrepresentation of iTLE patients with 80M
expression compared to our bioinformatics analysis (26 vs. 20%
in Europe), and the mismatch between increased GlyR RNA
editing in the W2-4 group of iTLE patients with Apobec-1 80M
expression suggests that other C-to-U RNA editing enzymes have
contributed to GlyR RNA editing (including the GlyR α3 subunit)
in these patients. Furthermore, pronounced hippocampal cell
loss and the type of seizures in the W2-4 group of iTLE patients
with Apobec-1 80M expression suggests that Apobec-1 80M
targeted gene products are involved in neurodegeneration and
secondary generalization of seizure activity (SGTCS). In fact,
the success rate of our patch clamp analysis of neurons with
80M expression was rather low (38.1%), compared to 60.5%
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success rate in patch clamp experiments involving the 80I variant,
and 50% of W2-4 classified iTLE patients with Apobec-1 80M
expression experienced SGTCS. In contrast, the vast majority
(93%) of the iTLE patients with Apobec-1 80I mRNA expression
had simple or complex partial seizures. This fits well with
the observed phenotypes of animals with increased expression
of RNA-edited GlyR which exhibit cognitive dysfunction and
impairment of spatial and contextual fear memory (Winkelmann
et al., 2014; Çaliskan et al., 2016). Considering the rather low
fraction of RNA-edited GlyRs in patients with iTLE and assuming
a uniform receptor distribution in all neuronal compartments
supports the proposed pathogenic presynaptic role of these
receptors in response to low extracellular glycine concentrations,
due to the low capacitance of the presynaptic compartment
and that irrespectively of whether RNA-edited GlyR α2 or α3
is expressed (Meier et al., 2014, 2016), which is in agreement
with a previous study (Chen et al., 2014). However, it is
possible that only a few neurons or certain neuron types
generate larger amounts of RNA-edited GlyRs in iTLE and
contribute in a neuron type-specific way to different symptoms
(Winkelmann et al., 2014; Çaliskan et al., 2016). We cannot
rule out this possibility yet because bulk material was used for
investigation of GlyR α2 or α3 RNA editing in iTLE (Eichler et al.,
2008).
In conclusion, our study revealed human genetic APOBEC1
80M/I dimorphism as a new diagnostic marker in iTLE. The 80I
variant can contribute to simple or complex seizure activities
and increases protein expression of RNA-edited GlyR, which
would preferentially affect the presynaptic compartment and
hence trigger maladaptive and persistent dysregulation of neuron
gain control, resulting in simple or complex partial seizures.
In contrast, the 80M Apobec-1 variant is suggested to promote
neurodegeneration and secondary generalization of seizure
activity. Moreover, the results indicate that a complex interplay
of different C-to-U RNA editing enzymes regulates GlyR RNA
editing in iTLE, which remains to be characterized at the single
cell level for example by applying the technologies established
here to resected hippocampi from patients with iTLE. Finally, this
study provides the basis for a new mapping of epidemiology and
semiology of iTLE with regard to APOBEC1 80M/I alleles, which
can open avenues for further characterization of the functional
roles of Apobec-1 80M and 80I variants in healthy and diseased
brains.
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